2094. Acceptability of Antibiotic Substitutions for Fluoroquinolones and Third and Fourth-generation Cephalosporins: A Report from the VA-CDC Practice-Based Research Network (PBRN)

BACKGROUND: Studies suggest fluoroquinolones (FQ), and third (3C) and fourth (4C) generation cephalosporins, agents often used for empiric therapy, place patients at higher risk for C. difficile infection. Substituting alternative antibiotics for empiric therapy might reduce risk. We surveyed inpati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Goetz, Matthew B, Hockett Sherlock, Stacey, Goedken, Cassie, Balkenende, Erin C, Evans, Charlesnika T, Perencevich, Eli, Echevarria, Kelly, Reddy, Sujan, Neuhauser, Melinda M, Reisinger, Heather, Suda, Katie J
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809126/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1774
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares